Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is iBio, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-33.63%
EBIT Growth (5y)
-1.45%
EBIT to Interest (avg)
-21.65
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.01
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
26.85%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.46
EV to EBIT
-1.32
EV to EBITDA
-1.39
EV to Capital Employed
6.94
EV to Sales
30.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-524.50%
ROE (Latest)
-39.32%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Movement
7What is working for the Company
NET PROFIT(HY)
Higher at USD -12.21 MM
ROCE(HY)
Highest at -70.22%
RAW MATERIAL COST(Y)
Fallen by -97.59% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -88.84 %
EPS(Q)
Highest at USD -0.09
-21What is not working for the Company
NET SALES(HY)
At USD 0.1 MM has Grown at -50%
OPERATING PROFIT(Q)
Lowest at USD -6.7 MM
PRE-TAX PROFIT(Q)
Lowest at USD -6.49 MM
NET PROFIT(Q)
Lowest at USD -6.49 MM
Here's what is working for iBio, Inc.
EPS
Highest at USD -0.09
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Lowest at -88.84 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -97.59% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for iBio, Inc.
Net Sales
At USD 0.1 MM has Grown at -50%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Operating Profit
Lowest at USD -6.7 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -6.49 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -6.49 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Pre-Tax Profit
At USD -6.49 MM has Fallen at -29.16%
over average net sales of the previous four periods of USD -5.03 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -6.49 MM has Fallen at -29.16%
over average net sales of the previous four periods of USD -5.03 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)






